- Page 1 and 2:
20 12 Annual Report PHOSPHAGENICS P
- Page 3 and 4:
highlights March... April... May...
- Page 5 and 6:
03 Jonathan Addison Chairman & Inde
- Page 7 and 8:
COLLABORATIONS Strategic Collaborat
- Page 9 and 10:
The Phosphagenics Evolution THE STO
- Page 11 and 12:
“ We also reached agreement with
- Page 13 and 14:
Overview of our opioid development
- Page 15 and 16:
13 is branded as Butrans or Norspan
- Page 17 and 18:
Personal Care ASHLAND INC (FORMERLY
- Page 19 and 20:
BEAUTY IS MORE THAN SKIN DEEP 17 EL
- Page 21 and 22:
cellulite contour crème BioElixia
- Page 23 and 24:
Intellectual Property Title Countri
- Page 25 and 26:
2009 2008 2007 2006 6.8 7.8 22.2 23
- Page 27 and 28:
DR ESRA OGRU (AGED 37 YEARS) BSC (H
- Page 29 and 30:
Senior Management DR PAUL GAVIN Chi
- Page 31 and 32:
Phosphagenics Limited ABN 32 056 48
- Page 33 and 34:
Directors’ Report Your directors
- Page 35 and 36:
Directors’ Report continued Looki
- Page 37 and 38:
Directors’ Report continued Commi
- Page 39 and 40:
Directors’ Report continued REMUN
- Page 41 and 42:
Directors’ Report continued REMUN
- Page 43 and 44:
Directors’ Report continued Share
- Page 45 and 46:
Directors’ Report continued Share
- Page 47 and 48:
Exercise Price Expiry Date Net othe
- Page 49 and 50:
Exercise Price Expiry Date Net othe
- Page 51 and 52:
Fair value per performance right at
- Page 53 and 54:
Directors’ Report continued REMUN
- Page 55 and 56:
Auditors Independence Declaration 5
- Page 57 and 58:
Corporate Governance Statement cont
- Page 59 and 60:
Corporate Governance Statement cont
- Page 61 and 62:
Corporate Governance Statement cont
- Page 63 and 64:
Corporate Governance Statement cont
- Page 65 and 66:
Corporate Governance Statement cont
- Page 67 and 68: Consolidated statement of fi nancia
- Page 69 and 70: Consolidated statement of changes i
- Page 71 and 72: Notes to the consolidated fi nancia
- Page 73 and 74: Application date of standard Impact
- Page 75 and 76: Application date of standard Impact
- Page 77 and 78: Application date of standard Impact
- Page 79 and 80: Application date of standard Impact
- Page 81 and 82: Notes to the consolidated fi nancia
- Page 83 and 84: Notes to the consolidated fi nancia
- Page 85 and 86: Notes to the consolidated fi nancia
- Page 87 and 88: Notes to the consolidated fi nancia
- Page 89 and 90: Notes to the consolidated fi nancia
- Page 91 and 92: Notes to the consolidated fi nancia
- Page 93 and 94: Notes to the consolidated fi nancia
- Page 95 and 96: Notes to the consolidated fi nancia
- Page 97 and 98: Notes to the consolidated fi nancia
- Page 99 and 100: Notes to the consolidated fi nancia
- Page 101 and 102: Notes to the consolidated fi nancia
- Page 103 and 104: Notes to the consolidated fi nancia
- Page 105 and 106: Notes to the consolidated fi nancia
- Page 107 and 108: Notes to the consolidated fi nancia
- Page 109 and 110: Notes to the consolidated fi nancia
- Page 111 and 112: Notes to the consolidated fi nancia
- Page 113 and 114: Independent Auditor’s Report 111
- Page 115 and 116: Additional Shareholder Information
- Page 117: Additional Shareholder Information